News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry Michael O'Riordan December 19, 2016
News Daily News More A-fib, No Drop in Stroke or Death With Surgical Left Atrial Appendage Exclusion Todd Neale December 05, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Conference News AHA 2016 Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement Shelley Wood November 14, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Industry News Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events November 02, 2016
Presentation TCT 2016 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy November 01, 2016
Presentation TCT 2016 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White November 01, 2016
Presentation TCT 2016 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Martin W. Bergmann, Samir R. Kapadia, Jason H. Rogers November 01, 2016
Presentation TCT 2016 Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset Presenter: Martin W. Bergmann, Samir R. Kapadia, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient Presenter: Martin W. Bergmann, Samir R. Kapadia, Ashish Pershad November 01, 2016
Presentation TCT 2016 Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to All Patients With Atrial Fibrillation (I Would Want It!) Presenter: Andreas Baumbach, David Hildick-Smith, Ted Feldman November 01, 2016
Presentation TCT 2016 TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials Presenter: Zahid Amin, Jacqueline Saw, Luis Nombela-Franco October 31, 2016
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure) Presenter: A. Pieter Kappetein, Allan Schwartz, Samir R. Kapadia October 30, 2016
Presentation TCT 2016 Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide! Presenter: David R. Holmes Jr., Josep Rodés-Cabau, David Hildick-Smith October 30, 2016
Presentation TCT 2016 Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? No Chronic Anticoagulation Should be Offered First Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Stefan C. Bertog October 30, 2016
Presentation TCT 2016 TCT 648: Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement Presenter: Jean-Claude Laborde, Azfar G. Zaman October 30, 2016